N/A
N=197
Evaluation the Effectiveness of a Telemonitoring Program in a Cohort of COPD Patient With Frequent Readmissions
COPD
Bottom Line
View on ClinicalTrials.gov: NCT02528370 ↗Enrolled (actual)
197
Serious AEs
1.0%
Results posted
Feb 2021
Primary outcome: Primary: Number of Hospitalizations for COPD Exacerbation (eCOPD) — 1.1; 2.8 number of hospital admissions
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- telEPOC (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Dr. Cristobal Esteban
- Primary completion
- Aug 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Hospitalizations for COPD Exacerbation (eCOPD) |
1.1; 2.8 | — |
Summary
Observational non-randomized study with an intervention cohort from Hospital Galdakao-Usansolo with 119 patients and a control cohort from Hospital Cruces with 78 patients. The inclusion criteria were: being hospital admitted at least twice in the previous year or at least three times in the 2 previous years. The cohorts were follow-up for 2 years. Several clinical measurements like pulmonary function, exercise capacity, health related quality of life, limitation in daily life activities and anxiety and depression were recorded in both cohorts. Telemonitoring and an organized education program were only and exclusively applied in the intervention cohort.
Eligibility Criteria
Inclusion Criteria
- The inclusion criteria established were: having a COPD (COPD was confirmed if the post-bronchodilator forced expiratory volume in one second (FEV1) divided by the forced vital capacity was less than 0.7 (FEV1/FVC<70%) and having been admitted at least twice in the previous year or three times in the two previous years for a COPD exacerbation (eCOPD).
Exclusion Criteria
- Exclusion criteria were another significant respiratory disease, an active neoplasm, a terminal clinical situation, inability to carry out any of the measurements of the project, or unwillingness to take part in the study.
Data sourced from ClinicalTrials.gov (NCT02528370). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.